A novel strategy to express different antigens from one modified vaccinia Ankara vaccine vector
K. B. Lauer, E. A. McKenzie, Y. Hall, C.P.C. Gowda, P. Klapper, R. Borrow, P.J. Vallely, M. W. Carroll, T. J. Blanchard
The paper develops a modified Vaccinia Ankara vector expressing antigens from multiple pathogens and tests its immunogenicity in mice, finding that while MVA-specific antibodies were induced, no antibodies against RABV or HBV were detected.
bioRxiv · Sep 21, 2017 · PreprintImmunology